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Abstract
Approximately 15% of patients with acute coronary syndromes (ACS) develop posttraumatic
stress disorder (PTSD) due to their ACS event. We assessed whether ACS-induced PTSD
symptoms increase risk for major adverse cardiac events (MACE) and all-cause mortality (ACM)
in an observational cohort study of 247 patients (aged 25–93 years; 45% women) hospitalized for
an ACS at one of 3 academic medical centers in New York and Connecticut between November
2003 and June 2005. Within 1 week of admission, patient demographics, Global Registry of Acute
Coronary Events risk score, Charlson comorbidity index, left ventricular ejection fraction, and
depression status were obtained. At 1-month follow-up, ACS-induced PTSD symptoms were
assessed with the Impact of Events Scale-Revised. The primary endpoint was combined MACE
(hospitalization for myocardial infarction, unstable angina or urgent/emergency coronary
revascularization procedures) and ACM, which were actively surveyed for 42 months after index
event. Thirty-six (15%) patients had elevated intrusion symptoms, 32 (13%) elevated avoidance
symptoms, and 21 (9%) elevated hyperarousal symptoms. Study physicians adjudicated 21
MACEs and 15 deaths during the follow-up period. In unadjusted Cox proportional hazards
regression analyses, and analyses adjusted for sex, age, clinical characteristics and depression,
high intrusion symptoms were associated with the primary endpoint (adjusted hazard ratio, 3.38;
95% confidence interval, 1.27 – 9.02; p= .015). Avoidance and hyperarousal symptoms were not
associated with the primary endpoint. The presence of intrusion symptoms is a strong and
independent predictor of elevated risk for MACE and ACM, and should be considered in the risk
stratification of ACS patients.
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The experience of an acute coronary syndrome [ACS, i.e., myocardial infarction (MI),
unstable angina (UA)] can be traumatic for many patients (Doerfler & Paraskos, 2011). In
fact, approximately 15% of patients develop significant symptoms of posttraumatic stress
disorder (PTSD) due to an ACS (Ayers, Copland, & Dunmore, 2009; Gander & von Kanel,
2006). PTSD that occurs as a result of trauma in non-medical settings is associated with
increased risk for incident cardiovascular disease (CVD) (Falger et al., 1992; Kubzansky &
Koenen, 2009). Furthermore, a growing body of literature suggests that PTSD due to an
ACS can increase risk of ACS recurrence. The presence of PTSD due to an ACS has been
associated with increased cardiovascular hospital readmission(Shemesh et al., 2004), lower
treatment adherence (Shemesh et al., 2006; Shemesh et al., 2001), and poorer quality of life
(Doerfler, Paraskos, & Piniarski, 2005; Doerfler, Pbert, & DeCosimo, 1994; Gamper et al.,
2004; Ladwig et al., 1999). Indeed, a recent study of Swiss post-MI patients found a 42%
increased risk of nonfatal ACS recurrence associated with each 10-point higher level of
PTSD symptoms (von Kanel et al., 2011). However, previous research has either considered
only nonfatal hospital readmissions, failed to control for potential confounders of the
relationship between PTSD and outcomes including medical comorbidities and depression
(an established psychosocial predictor of ACS recurrence), or both. Further, previous
research has focused on only one category of ACS patients (e.g., MI only), rather than
considering a sample of diverse ACS diagnoses.
The diagnosis of PTSD consists of symptoms that have been organized into three clusters:
intrusions, avoidance, and hyperarousal (King, Leskin, King, & Weathers, 1998). Intrusion
symptoms include intrusive thoughts or images related to the traumatic event, nightmares,
and flashbacks; avoidance symptoms include efforts to avoid stimuli related to the traumatic
event; and hyperarousal symptoms include difficulty concentrating, insomnia, and
hypervigilance to environmental threats. As with other psychiatric disorders known to
influence cardiovascular outcomes, specific symptoms or features of the disorder may carry
the bulk of the cardiovascular risk whereas others may not (Davidson et al., 2010). The
independent relationships of PTSD symptom clusters to post-ACS prognosis has not been
previously reported, though recent evidence suggests that intrusion symptoms may be the
most important cluster for predicting CVD risk (Newton, Parker, & Ho, 2005; von Kanel et
al., 2011; von Kanel et al., 2008). It is particularly important to adjust for depression when
assessing the independent relationships between PTSD symptom clusters and adverse
outcomes, given that the two disorders are often comorbid, and individuals with depression
often score similarly to those with PTSD on avoidance and especially hyperarousal (i.e.,
more so than intrusions, which appear to be relatively unique to PTSD) (Shalev et al., 1998).
The aim of this study was to explore the relationship of PTSD symptom clusters with
recurrent cardiac events and all-cause mortality after ACS. Consistent with the literature
discussed above, we hypothesized that the intrusions symptoms cluster would be most
strongly associated with cardiovascular risk and all-cause mortality among patients who
develop elevated PTSD symptoms after ACS.
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Data for this study come from the Coronary Psychosocial Evaluation Studies (COPES), a
series of studies that examined the association between depression and post-ACS prognosis.
Details of this study have been previously described (Davidson et al., 2010). The parent
study included 457 post-ACS patients who were admitted to the coronary care and cardiac
care telemetry units of 3 university hospitals (Mount Sinai Medical Center, New York, NY,
and Yale–New Haven Hospital and Hospital of St Raphael, New Haven, CT) between May
2003 and June 2005. The protocol complies with the Declaration of Helsinki. The
Institutional Review Boards of each hospital approved the study, and informed consent was
obtained from all participants after the study had been fully explained.
Inclusion Criteria
Patients were eligible if they met standard criteria for ACS (Cannon et al., 2001) (either
acute MI with or without ST-segment elevation or unstable angina with documentation of
coronary artery disease) verified by the study cardiologists and had eligible scores on the
Beck Depression Inventory (BDI) (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961); 0–4,
indicating minimal depressive symptoms, or ≥ 10, indicating at least mild depressive
symptoms) within 1 week after the index ACS hospitalization. Additionally, patients were
aged 18 years or older, and spoke English or Spanish. Patients with BDI scores between 5
and 9 were not enrolled in the parent study to more clearly delineate depressed and non-
depressed groups at baseline. Patients were also ineligible for study participation if they had
a terminal illness (life expectancy < 1 year), had current alcohol and/or substance abuse, or
had cognitive impairment as indicated by a Mini-Mental State examination score less than
24 (for educational level of 8th grade or higher) or less than 17 (for educational level of
lower than 8th grade). Patients were also excluded if the screening could not be completed
within 1 week of their initial hospitalization date or if they were unavailable for follow-up
visits. To be eligible for this substudy, patients had to have completed the assessment of
PTSD symptoms, which was initiated in November 2003, with 333 of the overall 457 patient
cohort enrolled after this time point.
Assessment of Posttraumatic Stress Disorder Symptoms
Posttraumatic stress disorder symptoms were assessed 1 month after the baseline interview
using the self-report Impact of Events Scale-Revised (IES-R) [23]. Participants reported on a
5-point scale ranging from 0 (“not at all”) to 4 (“extremely”) the extent to which they had
been bothered by each of 22 PTSD symptoms (intrusions - 8 items, e.g., “Pictures about it
popped into my mind;” avoidance - 8 items, e.g., “I stayed away from reminders about it;”
hyperarousal - 6 items, e.g., “I was jumpy and easily startled”) in the past week with
reference to their index hospitalization for ACS (i.e., “Think about when you were
hospitalized on (date) and we enrolled you in this study. In the past 7 days have you been
bothered by any of the following in reference to that hospitalization?”).
Covariates
The Global Registry of Acute Coronary Events (GRACE) risk score (Fox et al., 2006) and
Charlson comorbidity index (Charlson, Szatrowski, Peterson, & Gold, 1994)were obtained
through a combination of chart review and self-report. The GRACE score is an empirically
derived prognostic risk index based on clinical predictors available at the time of an ACS.
GRACE variables include age, history of MI or congestive heart failure, heart rate, systolic
blood pressure and serum creatinine at hospital presentation, and ST segment deviation,
elevated cardiac enzymes, and percutaneous intervention (PCI) during hospitalization (Eagle
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et al., 2004). The Charlson comorbidity index consists of 22 medical conditions weighted by
their associated mortality risk. The left ventricular ejection fraction (LVEF) that was most
proximate to the baseline cardiac event was abstracted from the chart, and was measured
quantitatively by either ventriculogram (43% of patients), echocardiogram (50% of
patients), or nuclear study (7% of patients). If multiple indices were available, the
ventriculogram was utilized. Values for LVEF were then categorized as normal/mild
dysfunction (LVEF ≥ 40%) and moderate/severe dysfunction (LVEF < 40%). Depression
symptom severity was measured with the Beck Depression Inventory (BDI) [22], a 21-item
measure that assesses depression symptoms experienced in the past week.
Ascertainment of Medical Outcomes
The primary end point for this study was either the first recurrence of a major adverse
cardiovascular event (MACE) [hospitalization for nonfatal MI, unstable angina, or urgent/
emergency coronary revascularization procedures (percutaneous coronary intervention,
coronary artery bypass grafting, or percutaneous transluminal coronary angioplasty)] or all-
cause mortality (ACM) within 42 months of the baseline interview. Study participants were
contacted at 1, 3, 6, 18, 30, and 42 months either by telephone or reported to the study site in
person to provide follow-up data. For any patient-reported hospitalization, supporting
documentation of the event was procured from hospital records. Additionally, all
recruitment hospitals were proactively searched for possible MACE hospitalizations and
deaths. An end point committee consisting of 2 board-certified cardiologists, blinded to
PTSD and depression status, independently reviewed and classified each hospitalization; in
case of disagreement, a third board-certified cardiologist adjudicated the final end point. For
participants who could not be contacted or were reported deceased by a relative, the Social
Security National Death Index was searched to verify vital status.
Statistical Analysis
A total PTSD score of 33 on the IES-R has been found to best discriminate participants with
a PTSD diagnosis from those without (Creamer, Bell, & Failla, 2003). Thus, scores on each
of the 3 subscales were dichotomized into high and low categories, with a score of 11 or
greater classified as high, and a score of less than 11 classified as low. Previous studies of
PTSD and adverse outcome in MI survivors have used a similar approach (Shemesh et al.,
2000; Shemesh et al., 2001; Shemesh et al., 2004). In this study, PTSD scores were severely
positively skewed, and no transformation resulted in a normal distribution of scores, so
analyses with continuous PTSD scores were not conducted. Student’s t test for continuous
variables and χ2 test for categorical variables were used to compare those with and without
high levels of intrusion symptoms on demographic, psychiatric, and medical variables.
The primary analysis concerned the relationship between PTSD intrusion symptoms and
MACE/ACM over the 41-month period between the 1-month post-ACS assessment for
PTSD symptoms and the final follow-up. Patients who experienced a MACE/ACM between
enrollment and the 1-month PTSD assessment were removed from analyses. We followed
the recommendation that covariates be selected for inclusion a priori (Freedland et al.,
2005). Based on published findings of factors that might confound the association between
PTSD and MACE/ACM, demographic variables (age, sex), medical covariates (LVEF,
medical comorbidities (Charlson), a clinical prognostic index (GRACE), and depression
were treated as covariates. Three Cox proportional hazards models (adjusted for
demographics only; demographics and medical covariates; and demographics, medical
covariates, and depression) were tested to estimate the adjusted hazard ratios (HR) of post-
ACS MACE/ACM by level of PTSD intrusion symptoms. For each model, a test of the joint
statistical significance of the 3 symptom clusters is presented, as well as the significance
level of each symptom cluster, controlling for the others. For scale scores, missing values
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were imputed with expected values using multiple regression. All analyses were performed
using statistical software (SPSS 16.0, SPSS Inc, Chicago, IL).
RESULTS
Participants
Fourteen of 261 patients (5.4%) who completed the IES-R at the 1-month follow-up
experienced a recurrent MACE between baseline and the 1-month PTSD assessment and
were removed from analyses. Of the remaining 247 patients, the mean age was 60 years
(range, 25–93), 110 (45%) were women; 199 (80%) were White; and 21 (9%) were
Hispanic. 111 patients (45%) were diagnosed with unstable angina; 60 patients (24%) with
ST-segment elevation MI, and 76 patients (31%) with non ST-segment elevation MI. Using t
and χ2 tests, patients who completed the IES-R (n = 261) were compared with those who
were enrolled after this scale was added to the protocol but who did not complete it (n = 72).
Patients who completed the IES-R had a significantly lower GRACE score (88.5 vs 99.5, p
< .05) and were significantly less likely to have had a recurrent MACE or ACM (19% vs
40%, p < .05).
Overall the mean length of follow-up was 23.94 months per participant. One participant was
lost to follow-up prior to study end date.
PTSD Symptoms
Mean IES-R score in the sample was 11.45 (SD, 14.92). Twenty-eight patients (11%) met
the cutoff score for “likely PTSD” (i.e., total score ≥ 33); 36 (15%) for high intrusions; 32
(13%) for high avoidance; and 21 (9%) for high hyperarousal. Symptom clusters of PTSD
were highly associated (r > 0.80 for continuous variables; φ = .63–.69 for dichotomized
variables). Demographic and medical variables at baseline according to PTSD intrusion
symptom status are shown in Table 1. As expected, patients with high PTSD intrusion
scores reported higher avoidance and hyperarousal symptoms, and higher depression
symptom severity. Furthermore, participants with high intrusion scores had significantly
higher Charlson comorbidity scores.
MACE/ACM
During the 41 months following the 1-month assessment, 21 patients (9%) experienced a
recurrent MACE (13 UA, 4 MI, 4 emergency revascularizations) and 21 (9%) died. Given
that patients’ data were censored after the first MACE occurred, the combined outcome
MACE/ACM comprised 21 MACE events and 15 deaths (36 adverse events total, 15%).
Unadjusted Associations of PTSD Classification and PTSD Symptoms with MACE/ACM
Without adjustment for covariates, PTSD classification (total IES-R score ≥ 33) was
associated with MACE/ACM (HR = 2.42; 95% confidence interval [CI], 1.10 – 5.35).
Further, as hypothesized, high intrusions (score ≥ 11) was a strong predictor of MACE/
ACM (HR= 3.00; 95% CI, 1.47 – 6.12). Overall, 11 of 36 patients (31%) classified with
high intrusions had a recurrent MACE or ACM during the follow-up period compared with
25 of 211 patients (12%) classified with low intrusions. Neither high avoidance (HR=1.67;
CI, 0.74 – 3.87) nor high hyperarousal (HR= 0.85; CI, 0.26 – 2.85) were significantly
associated with MACE/ACM in unadjusted analyses.
Risk-Adjusted Associations of PTSD Classification and PTSD symptoms with MACE/ACM
After adjustment for demographic and medical covariates, a trend for an independent
association of PTSD classification with MACE/ACM existed (HR=2.04; CI, .86 – 4.86),
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however, after adjustment for the effect of depression, the relationship was attenuated
(HR=1.36, CI= .54 – 3.46).
Table 2 presents the Cox proportional hazards regression analyses for the independent
associations between PTSD symptom clusters and MACE/ACM. In the fully-adjusted model
with age, sex, GRACE risk score, Charlson comorbidity index, LVEF, and depression
classification, the simultaneous entry of PTSD intrusions, avoidance, and hyperarousal
classification improved the model (Δχ2 = 7.67; P= .05), but only intrusions (not avoidance
or hyperarousal) significantly predicted recurrent MACE/ACM. Of note, in the fully-
adjusted model, both depression classification and intrusions were significant predictors of
MACE/ACM, beyond all other covariates (Table 2). In this model, patients classified as
high on intrusions had more than 3 times greater risk of MACE/ACM (HR= 3.35; CI, 1.27 –
8.80; P = .02) than those classified as low on intrusions (Figure 1).
We tested alternative models to ensure that these results were not dependent on our data
analysis decisions. Because the hyperarousal subscale of the IES-R is comprised of only 6
items, and the intrusions and avoidance subscales are comprised of 8 items, we repeated the
analyses with the hyperarousal subscale dichotomized at 7. We chose a cutpoint of 7 as this
resulted in 15% of the sample receiving a categorization as “high hyperarousal” which
paralleled the prevalence of “high intrusions” and “high avoidance” using the cutpoint of 11
on the other subscales. In the fully-adjusted model with the alternate hyperarousal variable,
the results were unchanged. Additionally, due to the strong positive relationship between the
intrusion and hyperarousal subscale scores and the trend toward a protective effect of
hyperarousal in the fully-adjusted model, we considered that including both in the model
might have artificially exaggerated the effect of each. To evaluate this possibility, we tested
a model without the hyperarousal subscale. The effect of intrusions remained significant and
was not substantially decreased (HR= 2.94; CI, 1.06 – 8.24).
DISCUSSION
We found that a considerable proportion of patients with acute coronary syndromes develop
elevated PTSD symptoms, and elevated intrusion symptoms in particular. Further, our
results confirm and extend prior findings of an association between post-ACS PTSD
symptoms and increased risk of recurrent MACE/ACM. In contrast to previous research
(Shemesh et al., 2004) that has demonstrated a relationship between elevated levels of ACS-
induced PTSD symptoms and cardiac readmission, we were able to adjust for clinical
covariates including both the GRACE risk score and Charlson co-morbidity index in the
current study. To our knowledge, this is the first study to highlight an independent
association of ACS-induced PTSD symptoms with risk of recurrent MACE/ACM, and the
first to show that the intrusion symptom cluster may specifically confer elevated risk. While
previous research has shown both an unadjusted (using the IES-R) and independent
association of PTSD classification (using a different PTSD measure) with cardiac
readmission, we found that after adjustment for medical covariates and depression, that the
hazard ratio associated with PTSD classification remained elevated but was attenuated in
this still relatively small sample. Of note, however, intrusion symptoms continued to be
associated with MACE/ACM even after adjustment for depression, thus demonstrating the
important and unique contribution of PTSD intrusions to post-ACS event-free survival.
Consistent with our hypothesis, high intrusion symptoms consequent to ACS were
associated with a greater than 3-fold increase in risk for recurrent MACE or ACM after up
to 41 months of follow-up, In contrast, avoidance and hyperarousal symptoms were
unrelated to post-ACS prognosis. Although some previous research (Shemesh et al., 2004)
has suggested that avoidance behaviors may lead to worse medication adherence and thus
Edmondson et al. Page 6













increased risk of hospital readmission, others have found that increased avoidance
symptoms are associated with lower ambulatory blood pressure (Newton et al., 2005). The
non-significant protective trend for hyperarousal symptoms may appear counterintuitive, as
one might expect that hyperarousal symptoms would be associated with increased
autonomic activity, and thus predictive of recurrent MACE/ACM. However, no research has
found a relationship between hyperarousal and MACE/ACM, and it is unclear the extent to
which cardiac medications such as beta-blockers influence the experience of PTSD-related
hyperarousal or the relationship between perceived hyperarousal and MACE/ACM risk.
Intrusion symptoms have consistently been related to cardiovascular outcomes and
physiologic markers of increased risk, and this study suggests that they may be the most
important symptoms of PTSD for the prediction of MACE or ACM. There is a sound
biological basis for the relationship, in that previous research has found that intrusions are
related to elevated systolic blood pressure, blood markers of endothelial dysfunction (von
Kanel et al., 2008), and higher circulating levels of both catecholamines (Davidson & Baum,
1986; Hawk, Dougall, Ursano, & Baum, 2000) and C-reactive protein (Miller, Sutherland,
Hutchison, & Alexander, 2001). Furthermore, intrusions have been associated with elevated
physiological stress response years after exposure to a traumatic event (Baum, Cohen, &
Hall, 1993), and a recent study of ambulatory cardiovascular functioning found that
intrusion symptoms, but not avoidance or hyperarousal symptoms, were related to elevated
mean awake ambulatory blood pressure (Newton et al., 2005).
Limitations
The present study relied on a self-report measure of PTSD symptom severity rather than on
a diagnostic interview. The specific measure employed does not cover all possible PTSD
symptoms, so the importance of a PTSD diagnosis for post-ACS event-free survival could
not be determined. Also, patients with BDI depression scores of 5–9 were excluded from the
parent study. The exclusion of these patients may have limited the variability in PTSD
scores in this sample, and may have resulted in an overestimate of the true prevalence of
PTSD symptoms. However, the possible range of BDI scores is 0–63, so scores between 5
and 9 are a relatively small portion of possible scores. Patients who were eligible but did not
complete the IES-R had worse prognosis. Accordingly, we may have underestimated the
true prevalence of elevated PTSD symptoms after ACS and the true magnitude of the PTSD
to MACE/ACM relationship. Further, this study would have been stronger if we had been
able to ascertain cause of death for the ACM outcome, given that PTSD due to non-ACS
events has been associated with cardiac mortality.
The large ratio of predictors to MACE or ACM events in the fully-adjusted models was not
ideal. Although it would have been preferable to test our hypotheses in a sample that
included 10 events for every predictor, the finding that intrusions were significantly
associated with MACE/ACM in the fully-adjusted model suggests that limited power was
not an issue. Moreover, the consistency between the significant unadjusted association
between PTSD symptoms and recurrent MACE/ACM (using a regression model in which
the predictor-to-event ratio was not a concern) and the fully-adjusted association further
supports our decision to control for theoretically important covariates even though the
predictor-to-event ratio was not ideal. Indeed, concerns about model overfitting forced us
not to consider other demographic and behavioral variables that could be thought to
influence the association between intrusions and MACE/ACM (e.g., income level,
smoking), but the fact that participants with high intrusions did not differ from those with
low intrusions on any measured variable not accounted for in the model diminishes our
concern about leaving them out. Finally, the use of dichotomous PTSD symptom variables
may represent a limitation of our study. However, this categorical approach is consistent
with the current classification scheme in the Diagnostic and Statistical Manual of Mental
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Disorders (Fourth Edition), and previous post-ACS PTSD research predicting adverse
medical outcomes has likewise used dichotomized scoring (Shemesh et al., 2006; Shemesh
et al., 2001; Shemesh et al., 2004).
Notwithstanding the aforementioned possible limitations, this study is by far the largest to
demonstrate an association between PTSD symptoms after ACS and recurrent MACE/ACM.
It is also the first to include mortality among the primary endpoints.
Conclusion
For many patients, an ACS is sufficiently traumatic to elicit PTSD symptoms. The findings
of the present study demonstrate that patients who have intrusive, emotionally-charged
thoughts, nightmares, or flashbacks related to their ACS may be at especially high risk for
MACE recurrence and mortality. Further study is needed to better characterize these patients
at high risk, to better illuminate the mechanisms underlying the relationship between PTSD
and CVD, and to assess the benefit of possible interventions.
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Cox proportional hazards regression analysis predicted curve for patients with and without
high levels of intrusion symptoms, adjusted for age, sex, Charlson comorbidity index score,
Global Registry of Acute Coronary Events risk score, left ventricular ejection fraction, and
depression symptom severity according to the Beck Depression Inventory. Also, the number
of patients in each group who were at risk for MACE/ACM at each year are presented below
the figure. Abbreviation: ACS, acute coronary syndrome.
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Table 1




High (n = 36) Low (n = 211)
Age, y 57.1 ± 12.2 60.7 ± 12.9
Male, n (%) 24 (67) 112 (53)
White, n (%) 28 (78) 171 (81)
Hispanic, n (%)b 7 (19) 15 (7)
Mean income $35–50,000 $35–50,000
Body mass index 28.55 (8.16) 28.99
GRACE risk score 80.2 ± 30.6 89.5 ± 32.5
ST-segment elevation MI, n (%) 8 (23) 51 (24)
Non-ST-segment elevation MI, n (%) 9 (26) 70 (33)
Unstable angina, n (%) 18 (50) 91 (43)
Charlson comorbidity indexb 2.1 ± 1.9 1.3 ± 1.6
Percutaneous transluminal coronary angioplasty, n (%) 30 (84) 158 (75)
C-reactive protein at baseline(n = 145) 24.9 ± 33.0 26.1 ± 41.5
C-reactive protein at 1-month (n = 120) 7.3 ± 8.6 5.7 ± 9.6
Left ventricular ejection fraction 53.8 ± 12.5 52.9 ± 14.1
Peak troponin 73.9 ± 148.2 116.3 ± 303.6
Peak creatinine kinase 1011.2 ± 1821.8 1019.5 ± 1545.6
 Left ventricular ejection fraction ≥ 40, n (%) 5 (13) 34 (16)
Diabetes, n (%) 15 (42) 62 (30)
Hypertension, n (%) 32 (89) 174 (85)
Endorsed recent alcohol consumption, n (%) 9 (27) 59 (30)
 Number of drinks in pre-event week 3.44 (4.25) 3.47 (3.52)
Smoking history, n (%) 26 (72) 121 (57)
Antidepressant use, n (%)c 12 (34) 29 (14)
BDI scorec 16.4 ± 12.1 7.3 ± 7.6
BDI score ≥ 10, n (%)c 28 (78) 87 (41)
IES-R scorec 21.1 ± 12.7 6.3 ± 7.5
 Total score ≥ 33, n (%)c 26 (72) 2 (1)
 Intrusionsc 16.3 ± 4.3 2.2 ± 2.7
 Avoidancec 14.5 ± 6.1 2.6 ± 3.5
  Avoidance ≥ 11, n (%)c 25 (69) 6 (3)
 Hyperarousalc 10.4 ± 5.3 1.5 ± 2.4
  Hyperarousal ≥ 11, n (%)c 18 (50) 2 (1)
Abbreviations: BDI, Beck Depression Inventory; IES-R, Impact of Events Scale–Revised; PTSD, posttraumatic stress disorder; MI, myocardial
infarction; GRACE, Global Registry of Acute Coronary Events
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